RxDoctor Payments Data

Kevin Crable

Primary Podiatric Medicine · Oneida, NYNPI 1891109278

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.

$3,063in general payments, 2019–2025

Across 107 payments — averaging $28.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hydrofera LLC$420
  • AbbVie$364
  • Smith+Nephew$308
  • Treace Medical Concepts, Inc.$260
  • Paratek Pharmaceuticals, Inc.$237
  • Aroa Biosurgery Incorporated$228
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,052100%
  • Entertainment$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,063 in reported general payments places this provider in the 80th percentile of 85 primary podiatric medicine providers in New York.

See all primary podiatric medicine providers in New York

Medicare billing

Part B allowed, 2024
$101,006
Medicare patients
509
Services billed
2,071

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole46$1,671
Ciclopirox24$1,298
Betamethasone Dipropionate14$1,015
Clotrimazole36$785
Ammonium Lactate27$669
Triamcinolone Acetonide23$461
Mupirocin51$396
Doxycycline Hyclate37$384
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$161
Methylprednisolone20$153
SsdSilver Sulfadiazine11$94
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$78
Levofloxacin15$65
Meloxicam11$13

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Oneida

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →